Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency
Monogenic and polygenic mutations are important contributors in patients suffering from epilepsy, including metabolic epilepsies which are inborn errors of metabolism with a good respond to specific dietetic treatments. Heterozygous variation in solute carrier family 2, facilitated glucose transport...
Main Authors: | Armond Daci, Adnan Bozalija, Fisnik Jashari, Shaip Krasniqi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/1/122 |
Similar Items
-
Glucose Transporter 1 deficiency and associated conditions in children
by: R. G. Gamirova, et al.
Published: (2019-11-01) -
Clinical Variability of GLUT1DS
by: Anastasia Martinez-Esteve Melnikova, et al.
Published: (2015-02-01) -
Glucose transporter type 1 deficiency syndrome (GLUT1-DS) – delayed diagnosis and treatment. A case report
by: Piotr Bogucki, et al.
Published: (2019-03-01) -
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group
by: Joerg Klepper, et al.
Published: (2020-09-01) -
Glucose Transporter Type 1 Deficiency Syndrome: A Single-Center Case Series
by: Miraç Yıldırım, et al.
Published: (2021-09-01)